Edition:
India

AveXis Inc (AVXS.OQ)

AVXS.OQ on NASDAQ Stock Exchange Global Select Market

96.10USD
22 Nov 2017
Change (% chg)

$0.11 (+0.11%)
Prev Close
$95.99
Open
$96.25
Day's High
$97.28
Day's Low
$94.32
Volume
92,511
Avg. Vol
155,681
52-wk High
$108.27
52-wk Low
$44.68

Select another date:

Fri, Nov 10 2017

BRIEF-Avexis posts Q3 loss per share $1.52

* Avexis reports third quarter 2017 financial and operating results

BRIEF-Avexis Inc CFO Thomas Dee resigns

* Avexis Inc - ‍on October 14 Thomas J. Dee resigned as senior vice president, chief financial officer - SEC filing

BRIEF-AveXis to report top-line data from phase 1 clinical trial of AVXS-101

* AveXis to report top-line data from the Phase 1 clinical trial of AVXS-101 in SMA Type 1 at the International Annual Congress Of The World Muscle Society

BRIEF-Avexis to initiate pivotal trial of AVXS-101 in SMA type 1

* Avexis announces plan to initiate pivotal trial of AVXS-101 in SMA type 1 using product from new GMP commercial process

BRIEF-AveXis reports Q2 loss per share $2.07

* AveXis reports second quarter 2017 financial and operating results

BRIEF-Avexis announces alignment with FDA on GMP commercial manufacturing process for AVXS-101

* Avexis announces alignment with FDA on GMP commercial manufacturing process for AVXS-101

BRIEF-Avexis and Regenxbio announce new exclusive worldwide licenses

* Avexis and Regenxbio announce new exclusive worldwide licenses for the treatment of two rare neurological monogenic disorders using NAV AAV9 vector

Select another date: